Evidence map›Paper›PMID 26694030›Full record

ArticleNature communications2015

Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum.

Jigang Wang, Chong-Jing Zhang, Wan Ni Chia, Cheryl C Y Loh, Zhengjun Li, Yew Mun Lee, Yingke He, Li-Xia Yuan, Teck Kwang Lim, Min Liu and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 275 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed, 4 pooled it
53.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 4 syntheses or guidelines pooled it, 631 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Jigang WangDepartment of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
Chong-Jing ZhangDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore.
Wan Ni ChiaDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Cheryl C Y LohDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Zhengjun LiNUS Environmental Research Institute, Singapore 117411, Singapore.
Yew Mun LeeDepartment of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.ORCID http://orcid.org/0000-0002-8360-7689
Yingke HeDepartment of Anaesthesiology, Singapore General Hospital, Singapore 169608, Singapore.
Li-Xia YuanSchool of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, China.
Teck Kwang LimDepartment of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
Min LiuInterdisciplinary Research Group in Infectious Diseases, Singapore-MIT Alliance for Research &Technology (SMART), Singapore 138602, Singapore.
Chin Xia LiewNUS Environmental Research Institute, Singapore 117411, Singapore.ORCID http://orcid.org/0000-0001-9620-2405
Yan Quan LeeDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Jianbin ZhangDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Nianci LuCollege of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Chwee Teck LimDepartment of Biomedical Engineering, National University of Singapore, Singapore 117583, Singapore.
Zi-Chun HuaThe State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing 210023, China.
Bin LiuDepartment of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore.
Han-Ming ShenDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
Kevin S W TanDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
Qingsong LinDepartment of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
National University of Singapore · SGChina Pharmaceutical University · CNSingapore Clinical Research Institute · SGBeijing University of Chemical Technology · CNSingapore General Hospital · SGSingapore-MIT Alliance for Research and Technology · SGSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mechanism of action of artemisinin and its derivatives, the most potent of the anti-malarial drugs, is not completely understood. Here we present an unbiased chemical proteomics analysis to directly explore this mechanism in Plasmodium falciparum. We use an alkyne-tagged artemisinin analogue coupled with biotin to identify 124 artemisinin covalent binding protein targets, many of which are involved in the essential biological processes of the parasite. Such a broad targeting spectrum disrupts the biochemical landscape of the parasite and causes its death. Furthermore, using alkyne-tagged artemisinin coupled with a fluorescent dye to monitor protein binding, we show that haem, rather than free ferrous iron, is predominantly responsible for artemisinin activation. The haem derives primarily from the parasite's haem biosynthesis pathway at the early ring stage and from haemoglobin digestion at the latter stages. Our results support a unifying model to explain the action and specificity of artemisinin in parasite killing.

Indexed as

AntimalarialsArtemisininsChemical EngineeringHemeModels, MolecularMolecular StructurePlasmodium falciparumProtein ConformationProtozoan ProteinsAntimalarialsartemisininArtemisininsHemeProtozoan Proteins

Identifiers

PMID26694030
PMCPMC4703832
OpenAlexW2234562695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.